Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
about
How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future DirectionsEnteral feeding and its impact on the gut immune system and intestinal mucosal barrierThe bacteriome-mycobiome interaction and antifungal host defensePrevention of bacterial infection in pediatric oncology: what do we know, what can we learn?The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal CarcinomaThe COLON study: Colorectal cancer: Longitudinal, Observational study on Nutritional and lifestyle factors that may influence colorectal tumour recurrence, survival and quality of lifeCan prebiotics and probiotics improve therapeutic outcomes for undernourished individuals?Oral microbiota distinguishes acute lymphoblastic leukemia pediatric hosts from healthy populations.Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprintingBlood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associatedOral bacterial community dynamics in paediatric patients with malignancies in relation to chemotherapy-related oral mucositis: a prospective studyEmerging roles of the microbiome in cancer.TLR signaling modulates side effects of anticancer therapy in the small intestine.The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patientsThe surface rhamnopolysaccharide epa of Enterococcus faecalis is a key determinant of intestinal colonization.Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications.Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model.Food-borne bacteremic illnesses in febrile neutropenic children.Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets.Low-dose irradiation affects the functional behavior of oral microbiota in the context of mucositis.The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.Gut microbiota modulation of chemotherapy efficacy and toxicity.Obesity and Metabolic Disease After Childhood CancerFecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twinsRelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation.The host selects mucosal and luminal associations of coevolved gut microorganisms: a novel concept.Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy.Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.Interaction between host cells and microbes in chemotherapy-induced mucositis.Microbiota and their role in the pathogenesis of oral mucositis.The role of oral flora in the development of chemotherapy-induced oral mucositis.The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?The role of the microbiome in cancer development and therapy.16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro.The gut microbiome, symptoms, and targeted interventions in children with cancer: a systematic review.
P2860
Q26771113-49923890-BF3F-4039-B5E1-BBEBAE7275B1Q26777672-8F1B6BB8-90DA-4B7A-B452-D46FD9EDFEEEQ26851477-120847E5-4C32-483B-9F77-F9D2F8588A72Q33559453-531325F2-F6CC-4FBD-8D17-F0C8FBA960C3Q33594436-6C1AEB2C-7157-42A1-9EC1-00FA9B6F2943Q33603216-E98E82CA-2669-4616-A371-D7F39B43431BQ33713040-D8B797D0-5BB6-4F4A-803C-1EB3BB388D3FQ33728328-E5A94BA6-63D5-4055-A9CF-CB968201D13CQ33904067-F2AD5114-B041-44F3-B886-91A2D5E5E892Q34110225-8F361005-29AC-4D7D-886B-28177B36162FQ34626390-C541A8BA-0841-4C51-ADEC-C007568F3D42Q34799946-DE43C47B-78CC-4916-BBF8-917CC7B959E8Q35058372-27F3D1AC-45D4-43B0-8643-550E4DB5FF90Q35114570-9FA61DC6-BC5A-4924-AD97-EC32B178D6FDQ35152783-75B382C8-AF48-4C95-AF42-AAFC754D048BQ35208666-78DC9DB8-BF6E-495B-9449-C06CF309B17BQ35209399-BE4B0630-9436-495D-B349-871DA0E21D9FQ35400815-CDCFF485-BDBC-475F-9F9F-55DFE58511BAQ35615338-3934B746-5B60-4DF7-8FC7-7E6F00961036Q35644295-8AF2C18B-D745-4707-A880-2BA8F8B1E3C9Q35706909-234364AB-751B-4DCD-BF54-8BA461306556Q36007787-73C34CAE-6CD2-41D2-88E9-CA7598B0D437Q36081373-1C63E8A3-9426-487E-B26D-813EF83ED428Q36300217-E344BBD2-AA4A-4B31-A38C-8B04C0D468EEQ36588407-1095E2D2-3F08-4912-A62F-A53B33008B08Q36746790-9CE38CC1-087A-41CD-ABB0-1EF24BCD9C3AQ37556629-D7C27E97-E3C8-4016-BAD0-DA56EB3E225BQ37713517-0C74FBC6-4B74-4496-96B9-400276BD32F4Q37848454-35803047-3991-47F9-B4FB-7C3770D08B70Q37915052-073DF422-FD43-4C58-986F-60DDCA02C546Q38088252-F6C762CF-872C-4468-B7BA-6FF1ED851E16Q38102867-7DE339A2-AA4A-48DF-AFD2-12E96E45BE8CQ38181186-A5D9279A-B131-45B1-ADEE-6D0586811E4BQ38185099-B4E6882B-8C6D-404F-927D-EE3A3B618408Q39035437-615FA692-6486-4486-A94C-488547AE2B89Q39180730-B9B1814C-1C9D-4D87-967A-FF77B47B4FC0Q39290620-9DD12A14-C460-4298-B976-95D5032DD9D0Q43548235-0C3D0745-F19E-42EC-B8BA-DDE3CB34C522Q46257516-FA8C314D-9A38-4517-BE95-BFF67EBE4EBAQ47425267-F5E0E0CB-45E4-4252-80D4-0D9F8E5D8C79
P2860
Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@ast
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@en
type
label
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@ast
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@en
prefLabel
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@ast
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@en
P2093
P356
P1476
Chemotherapy treatment in pedi ...... athogenic bacteria in the gut.
@en
P2093
Catharina A J Dun
Eveline S J M de Bont
Hermie J M Harmsen
Michel J van Vliet
Nico E L Meessen
Willem A Kamps
Wim J E Tissing
P304
P356
10.1086/599346
P407
P577
2009-07-01T00:00:00Z